Altered ARID1A was also found to be associated with significantly shorter DFS and OS in the cohort, in concordance with the result of an earlier study enrolling 109 micro‐dissected pancreatic ductal adenocarcinoma cases.29 This evidence concerns the gene ARID1A and pancreatic ductal adenocarcinoma.